focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 304.00
Bid: 296.00
Ask: 304.00
Change: -1.00 (-0.33%)
Spread: 8.00 (2.703%)
Open: 295.00
High: 304.00
Low: 295.00
Prev. Close: 305.00
FSJ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exclusive UK Partnership

25 Jan 2007 07:02

Fisher (James) & Sons PLC25 January 2007 For release 7am Thursday 25 January 2007 James Fisher Announce Exclusive UK Partnership with Synodys Group James Fisher IMS, a subsidiary of James Fisher and Sons plc, the marine andengineering services business, announce a strategic partnership with the SynodysGroup, the global instruments and monitoring systems company. James Fisher IMS provides inspection and measurement capability to the nuclear,homeland security, defence and aerospace industries. The Synodys Health PhysicsDivision provides active dosimetry, passive dosimetry, and contamination andclearance systems as services to nuclear, military and civil defence, andmedical markets. The division is headquartered in Lamanon, France, and sellsunder the Synodys, MGP, and Rados brands. The partnership provides James Fisher IMS, which has a strong UK presence andexcellent reputation, with a comprehensive portfolio of radiation measurementsystems to satisfy its customer requirements. The UK market focus, commitmentand resources that Fisher brings to the partnership represent a major stepforward for Synodys in the UK. James Fisher IMS is now the exclusive partner for UK sales, support and service.The UK customer base is of major importance to Synodys and this partnershipsupports the goal of enhancing coverage, technical support and services to ourcustomers. Paul Read, Managing Director, James Fisher IMS, comments: "The partnership with Synodys is an important element in our strategy ofproviding the customer base with a comprehensive product and service portfolioin all markets were quality, responsiveness and value are key to our customers." Antony Besso, CEO, Synodys Health Physics, said: "James Fishers commitment to the UK customer base, coverage and complimentarycapabilities make it an ideal partner for both products and services." - ENDS - For more information contact: James Fisher IMSwww.james-fisher.co.ukPaul Read, Managing Director paul.read@jfims.co.uk 0161 232 1414 Synodys Steve Phillips sphillips@mgpi.com.fr +33 (0)490 595 959 Adventis Financial PR Peter Binns pbinns@adventis.co.uk 020 7034 4760 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Apr 20245:39 pmRNSAnnual Report and Accounts 2023 and Notice of AGM
16th Apr 20247:00 amRNSPreliminary results for the year ended 31 Dec 2023
22nd Mar 20247:00 amRNSProposed disposal of RMSpumptools business
16th Feb 20244:30 pmRNSHolding(s) in Company
13th Feb 20245:52 pmRNSNotification of Major Holdings
13th Feb 20245:50 pmRNSHolding(s) in Company
8th Feb 20247:00 amRNSFull Year Trading Update
25th Jan 20247:00 amRNSAppointment of Independent Non-Executive Director
20th Dec 20236:06 pmRNSNotification of Director’s Interests in Shares
15th Dec 20233:07 pmRNSBLOCK LISTING SIX MONTHLY RETURN
22nd Nov 20234:06 pmRNSHolding(s) in Company
9th Nov 20231:59 pmRNSBoard Changes
26th Oct 20237:30 amRNSDirector Declaration
2nd Oct 20239:00 amRNSTotal Voting Rights and Share Capital
25th Sep 202311:29 amRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSHalf year results
3rd Aug 20237:00 amRNSAppointment of Chief Financial Officer
17th Jul 20237:01 amRNSBoard Change
17th Jul 20237:00 amRNSHalf year trading update
6th Jul 20237:00 amRNSHolding(s) in Company
15th Jun 20233:18 pmRNSBLOCK LISTING SIX MONTHLY RETURN
14th Jun 20234:18 pmRNSResults of Annual General Meeting (“AGM”)
14th Jun 20237:00 amRNSAGM Trading Statement
12th Jun 20234:24 pmRNSNotification of Directors' Interests in Shares
9th Jun 20233:53 pmRNSNotification of Directors' Interest in Shares
7th Jun 20237:00 amRNSCompletion of refinancing
12th May 20234:49 pmRNSAnnual Report and Accounts 2022 and Notice of AGM
2nd May 20237:00 amRNSUpdate on full year results
28th Apr 20237:58 amRNSFull year results for the year ended 31 Dec 2022
26th Apr 20237:00 amRNSAgreed Revolving Credit Facility
28th Mar 20232:00 pmRNSHolding(s) in Company
24th Mar 20237:00 amRNSCorporate, Financing and Trading Update
6th Mar 20237:00 amRNSSale of JFN, Trading Update and Notice of Results
28th Dec 20227:00 amRNSSwordfish Dive Support Vessel sold for US$24m
19th Dec 20227:00 amRNSDisposal of three businesses
15th Dec 20224:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
19th Oct 20229:14 amRNSHolding(s) in Company
13th Sep 202212:59 pmRNSDirector/PDMR Shareholding
7th Sep 20227:00 amRNSHalf-year Report
1st Sep 20227:00 amRNSCompany Secretary Change
29th Jul 20224:39 pmRNSHolding(s) in Company
23rd Jun 20222:06 pmRNSHolding(s) in Company
17th Jun 20227:00 amRNSAppointment of Chief Executive Officer
15th Jun 20224:44 pmRNSBLOCK LISTING SIX MONTHLY RETURN
13th Jun 20227:00 amRNSCEO Update
6th May 20225:42 pmRNSHolding(s) in Company
5th May 20225:05 pmRNSResult of AGM
5th May 20227:00 amRNSAGM Trading Statement
25th Apr 20221:42 pmRNSDirector/PDMR Shareholding
30th Mar 20225:48 pmRNSAnnual Report and Notice of 2022 AGM posted

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.